This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Marina Yamaguchi: Innovator in Anti-Diabetic Drug Development
Introduction
Marina Yamaguchi is a prominent inventor based in Gotenba, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-diabetic drugs. Her innovative work has led to the creation of a unique compound that holds promise for diabetes treatment.
Latest Patents
Marina Yamaguchi holds 1 patent for her invention titled "Fused ring spiroketal derivative and use thereof as anti-diabetic drug." This patent provides a compound represented by Formula (I) or a prodrug thereof, as well as a pharmaceutical agent and a pharmaceutical composition containing such a compound or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
Career Highlights
Marina is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at Chugai has allowed her to focus on innovative drug development, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Marina has collaborated with notable colleagues, including Tsutomu Sato and Yoshihito Ohtake. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Marina Yamaguchi is a trailblazer in the pharmaceutical industry, with her innovative patent paving the way for new anti-diabetic treatments. Her contributions reflect the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile